Samir M. Gharib's Net Worth
$194 Thousand
Who is Samir M. Gharib?
Samir M. Gharib does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SPRUCE BIOSCIENCES, INC., and Talon Therapeutics, Inc..
SEC CIK
Samir M. Gharib's CIK is 0001533302
Past Insider Trading and Trends
2023 was Samir M. Gharib's most active year for acquiring shares with 8 total transactions. Samir M. Gharib's most active month to acquire stocks was the month of November. 2023 was Samir M. Gharib's most active year for disposing of shares, totalling 8 transactions. Samir M. Gharib's most active month to dispose stocks was the month of May. 2021 saw Samir M. Gharib paying a total of $21,870.26 for 503,632 shares, this is the most they've acquired in one year. In 2023 Samir M. Gharib cashed out on 302,074 shares for a total of $133,267.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SPRUCE BIOSCIENCES, INC. (SPRB) Snapshot price: $0.4418
PRESIDENT AND CFOSamir M. Gharib owns 202,776 units of Common Stock which is worth $89,586.44. From 2020 to 2024 Samir M. Gharib acquired a total of 293,068 shares in SPRUCE BIOSCIENCES, INC. at a cost of $51,175.69, Samir also disposed a total of 90,292 shares of SPRUCE BIOSCIENCES, INC. equalling to $155,831.37.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +5.88% | 11.26K |
$0.98 | $11,001.76 | 202.78K |
Dec 29
| |||
Form 4
| +66.01% | 76.16K |
$1.66 | -$59,917.70 | 191.52K |
Dec 14 - Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
| +106.68% | 59.55K |
$1.57 | -$55,762.40 | 115.37K |
Jun 30
| |||
Form 4
| +66.08% | 22.21K |
$1.04 | -$17,586.95 | 55.82K |
Dec 30 - Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +825.39% | 29.98K |
$1.61 | -$22,564.32 | 33.61K |
Jun 30
| |||
Form 4
| +92.04% | 2.22K |
$3.79 | $8,416.02 | 4.63K |
Dec 31 - Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
∞
| 1.41K |
$9.53 | $13,454.24 | 1.41K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Talon Therapeutics, Inc. No price found
Controller, Direct. Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9 - Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||